Accent Therapeutics Announces $63 Million Series B Financing to Advance Novel, Precision Cancer Therapies Targeting RNA-Modifying Proteins
Amount Raised
$63 Million
Round Type
Series B
United StatesBiotechnologyDescription
Accent Therapeutics, a biopharmaceutical company developing breakthrough treatments for cancer patients, announced today that it has completed a $63 million Series B financing. The Series B was led by EcoR1 Capital with participation by GV, AbbVie Ventures, The Mark Foundation for Cancer Research, NS Investment and Droia Ventures as well as existing investors, Atlas Venture and The Column Group.
Quick answer
Accent Therapeutics raised $63 Million in a Series B round, dated April 23, 2020. Accent Therapeutics is based in United States.
- How much did Accent Therapeutics raise?
- Accent Therapeutics raised $63 Million in a Series B round on April 23, 2020.
- What does Accent Therapeutics do?
- Accent is leading the translation of RNA-modifying protein (RMP) biology into promising new therapies by combining a robust chemical biology platform with rigorous approaches to target identification and validation.
- Where is Accent Therapeutics based and how big is it?
- Accent Therapeutics is based in United States.
- Who are the decision-makers at Accent Therapeutics?
- Fundz holds 1 contact at Accent Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Accent Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Lisata Therapeutics raised $2.2M (Seed) on June 5, 2020.
- CereVasc raised $11M on June 5, 2020.
- Kineta, Inc. raised $100K (Seed) on June 4, 2020.
- Laxmi Therapeutic Devices raised $3.6M (Seed) on June 4, 2020.
- Statera Biopharma raised $1.6M (Seed) on June 4, 2020.
- Milagen, Inc. raised $3.3M (Seed) on June 3, 2020.
Who to call at Accent Therapeutics, and when
A new round usually means Accent Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Accent Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Accent Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Accent Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Accent Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansAccent Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.